Clinical Trials Logo

Anxiety clinical trials

View clinical trials related to Anxiety.

Filter by:

NCT ID: NCT05809115 Active, not recruiting - Depression Clinical Trials

Addressing Caregiver Wellbeing and Improving Child Development

Start date: June 14, 2023
Phase:
Study type: Observational

The goal of this study is to study whether the investigators can improve maternal child bonding and ultimately development in young children by helping caregivers with food insecurity and mental health needs. Both food insecurity and maternal depression has been linked to delays in development for children. This is a clinical trial in the mothers of hospitalized children 0-3 years of age. Participants who consent will complete a screening survey on social needs, food insecurity, stress, depression, and anxiety. There is not a comparison group. All caregivers who are identified as having food insecurity and/or anxiety or depression will receive study interventions.

NCT ID: NCT05777044 Active, not recruiting - Depression Clinical Trials

The Effect of Hatha Yoga on Mental Health

Start date: September 9, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine the effects of a 10-week (2x a week; 45-minute per session) Hatha yoga intervention in adults ages 18-25 (n = 45) on mental health outcomes. The main questions it aims to answer are: What is the effect of a hatha yoga intervention on depression and anxiety symptoms? What is the effect of a hatha yoga intervention on electroencephalogram (EEG) alpha and theta band power? What is the effect of hatha yoga intervention on heart rate variability? Participants will be randomized to three groups: waitlist control (usual routine), Hatha yoga (experimental group), and meditation (active comparative group). Participants in the Hatha yoga experimental group will attend 10 weeks of twice-weekly 45-minute yoga sessions. The active comparison meditation group will participate in 10 weeks of twice-weekly 45-minute meditation sessions. The control group will continue with their usual routine. Researchers will compare changes in depression and anxiety symptoms, EEG alpha and theta band power, and heart rate variability between the three groups.

NCT ID: NCT05758636 Active, not recruiting - Anxiety Clinical Trials

The Effect of Emotional Freedom Technique on Anxiety Levels of Nurses Caring for COVID19 Patients

Start date: March 2, 2022
Phase: N/A
Study type: Interventional

It is very important to protect and improve the physical, mental and social health of nurses, especially in the event that nurses frequently encounter patients diagnosed or suspected of COVID-19 and are exposed to the virus for a long time due to the long duration of care, increasing cases and the death of their colleagues. Que et al., 2020). Current researches have made it necessary for nurses to have difficulties in effectively coping with the anxiety experienced in the COVID-19 pandemic, which has affected the whole world, and to apply new effective methods, as their training includes effective coping methods (Feinstein and Church, 2010). There are studies that are effective in reducing stress and anxiety, such as meditation, yoga, and breathing therapies, which are recommended to prevent the increase in stress and anxiety levels that may occur in nurses by evaluating the experienced situations (Labrague et al., 2020; Vieta et al., 2020). In addition to these applications, it is seen that Emotional Freedom Technique (EFT) has been increasingly used recently in controlling and reducing anxiety (Hartmann, 2016). EFT is a type of energy-based psychotherapy that combines the components of Western psychology and Eastern medicine, applied to eliminate negative thoughts and feelings and problems related to emotions (İnangil et al., 2020; Church, 2013). Although the EFT technique is used in many different areas today, its effect on the level of anxiety in nurses during the COVID-19 process is not yet known. As a result, to evaluate the effect of EFT, whose positive results have been proven by many studies, on the anxiety level of nurses caring for COVID-19 patients.

NCT ID: NCT05738967 Active, not recruiting - Depression Clinical Trials

Transdiagnostic Behavioral Therapy for Anxiety and Depression in Autistic Adolescents

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

This study tests the effectiveness of a transdiagnostic cognitive behavioral therapy for autistic youth with anxiety and/or depression.

NCT ID: NCT05684991 Active, not recruiting - Anxiety Clinical Trials

Prospective, Multi Centric, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KSM-66 Ashwagandha (Withania Somnifera) in Adults Experiencing High Stress and/or Anxiety

Start date: September 19, 2022
Phase: N/A
Study type: Interventional

This study is a multi-centre, multi-national, prospective, randomized, double-blind placebo-controlled study. The study lasts 12 weeks which includes 2 on-site visits and 2 remote visits. Primary objective is to compare the efficacy of KSM-66 Ashwagandha (Withania somnifera) versus placebo in adults experiencing high stress and/or anxiety. Secondary objectives to compare the safety of KSM-66 Ashwagandha (Withania somnifera) versus placebo in adults experiencing high stress and/or anxiety.

NCT ID: NCT05590741 Active, not recruiting - Depression Clinical Trials

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

Start date: November 16, 2022
Phase: N/A
Study type: Interventional

This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.

NCT ID: NCT05563857 Active, not recruiting - Depression Clinical Trials

Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions

Start date: October 19, 2022
Phase: N/A
Study type: Interventional

US residents who have gastrointestinal issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical sites.

NCT ID: NCT05561933 Active, not recruiting - Depression Clinical Trials

Scaling Well-Being for Educators During COVID-19

Start date: October 21, 2022
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial (RCT) of the four-week Healthy Minds Program (HMP) app Foundations training in employees of Jefferson County Public Schools (JCPS) in Louisville, KY. The study will enroll 1300 JCPS employees. After completing the baseline assessment, participants will be randomly assigned to the intervention (i.e., the Healthy Minds Program App) or to a "Choice" control condition. HMP assigned participants will receive instructions and support in downloading and activating the app. Choice assigned participants will receive a list of resources that are focused on the science of well-being and happiness consisting of TED talk videos and books. 10 copies of each suggested book will be available for participants to check out. TED talk video links will be provided and are free to watch. Each week during the 4-week intervention period, participants in both conditions will complete the same weekly set of measures. Within two-weeks following the end of the intervention period, all participants will complete the post-test assessment. Approximately five to six months following post-test, participants will complete the follow-up assessment. In addition to study team collected data, the research team will receive from the district multiple years of student records (e.g., standardized assessments, attendance, disciplinary referrals) linked to teachers (teachers only, not other categories of employees who choose to participate). The researchers predict that participants assigned to the intervention will demonstrate significantly reduced anxiety and depressive symptoms and significantly improved well-being after the intervention, and these improvements will persist at the follow-up (primary outcomes). It is hypothesized that baseline participant characteristics and early experience of the intervention will predict treatment adherence, study drop-out and outcomes, and that treatment engagement will moderate outcomes. In addition, the investigators predict that intervention period improvements on well-being skills assessed weekly will mediate long-term improvements on primary outcomes.

NCT ID: NCT05524402 Active, not recruiting - Anxiety Clinical Trials

Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

The investigator aims to conduct a pilot randomized controlled trial to test the feasibility of two symptom management programs for college-age individuals with recent concussions and anxiety, TOR-C 1 and TOR-C 2. The investigator will assess the feasibility of recruitment procedures (screening, eligibility, and enrollment) and data collection as well as the feasibility, credibility, and acceptability of the programs (adherence, retention, fidelity, and satisfaction), following prespecified benchmarks. Both programs will be delivered virtually (Zoom).

NCT ID: NCT05523414 Active, not recruiting - Anxiety Clinical Trials

The Effect of SKY Breath Meditation on Health and Well-being

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The goal of this pilot SKY (Sudarshan Kriya Yoga) Breath Meditation study is to establish feasibility and acceptability of the intervention; and investigate preliminary effectiveness of the intervention at the DNA methylation, RNA and protein levels in blood samples collected from participants before and after the 8 week SKY intervention. Primary outcomes also include preliminary effectiveness at the physiological level using a wearable device used for continuous monitoring. Secondary outcome measures include behavioral inventories.